Communiqués Zeo ScientifiX, Inc.

Actions

ZEOX

US68621D2062

Marché Fermé - OTC Markets Autres places de cotation 21:28:31 16/07/2024			Varia. 5j.	Varia. 1 janv.
2,41 ^USD	+0,42 %		+22,34 %	+136,27 %

14/06	Zeo ScientifiX, Inc. annonce ses résultats pour le deuxième trimestre et les six mois terminés le 30 avril 2024	CI
03/06	Zeo Scientifix, Inc. annonce des changements au sein de sa direction	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K	27/11	PU
Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K	09/08/23	PU
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06/06/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	15/05/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	01/05/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	21/04/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/03/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	08/03/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	14/02/23	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	23/12/22	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	01/12/22	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	25/11/22	AQ
OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷	22/11/22	EQ
Organicell Regenerative Medicine : Responds to Recent Promotional Activities Pursuant to OTC Markets Request - Form 8-K	21/11/22	PU
ORGANICELL REGENERATIVE MEDICINE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	21/11/22	AQ
OTCMKTS : $OCEL 📋 Organicell Activates COPD Trial at Mayo Clinic!	16/11/22	EQ
Can This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?	14/11/22	EQ
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?	10/11/22	EQ
ORGANICELL REGENERATIVE MEDICINE, INC. Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K/A)	12/10/22	AQ
ORGANICELL REGENERATIVE MEDICINE, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	12/10/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Zeo ScientifiX, Inc.

Actions

ZEOX

US68621D2062

Communiqués

Filtres